|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Elevated NMDA receptors in parkinsonian striatum显示文摘 | Weihmuller FB Ulas J Nguyen L | 1992 | Neuroreport1992，3，11： | 1 |
| 2 | Exploring problem decom- position in conceptual design among novice designers 显示文摘 | LIIKKANEN L A PERTI'ULA M | 2009 | Design Studies2009，30，1： | 1 |
| 3 | Publications of physical and rehabilitation medicine physicians concerning musculosk- eletal ultrasonography: an overview显示文摘 | Ula~li AM Kara M 0zgakar L | 2011 | J Rehabil Med2011，43，8： | 1 |
| 4 | Study of a winter PM episode in Istanbul using the high resolution WRF/CMAQ modeling system显示文摘 | ULAS L KOSTANDINOS M ALPER U | 2010 | Atmospheric Environment2010，44，26： | 1 |
| 5 | Representation plurality and fusion for 3-D face recognition 显示文摘 | GOKBERK B DUTAGACI H ULAS A AKARUN L SANKUR B | 2008 | IEEE Transactions on Systems Man and Cybernetics2008，38，1： | 1 |
| 6 | The transcriptional regulator network of human inflammatory macrophages is defined by open chromatin显示文摘 | Susanne V Schmidt Wolfgang Krebs Thomas Ulas Jia Xue Kevin BalBer Patrick Gunther Anna-Lena Hardt Hartmut Schultze Jil Sander Kathrin Klee Heidi Theis Michael Kraut Marc Beyer Joachim L Schultze | 2016 | Cell Research2016，26，2： | 1 |
| 7 | Elevated NMDA receptor in Parkinsonian striatum显示文摘 | Weihmuller F B Ulas J Nguyen L | 1992 | Neuroreport1992，3，： | 1 |
| 8 | Whole-genome annotation by using evidence integration in functional-linkage networks 显示文摘 | ULAS K MURALI T M STAN L | 2004 | Proc Natl Acad Sci USA2004，101，7： | 1 |
| 9 | Elevated NMDA receptors in parkinsonian striatum显示文摘 | Weihmuller FB Ulas J Nguyen L | 1992 | Neuroreport1992，3，11： | 1 |
| 10 | Evaluation of Factor V G1691A, prothrombin G20210A, Factor XIII V34L, MTHFR A1298C, MTHFR C677T and PAI-1 4G/5G genotype frequencies of patients subjected to cardiovascular disease (CVD) panel in south-east region of Turkey显示文摘 | Serdar Oztuzcu Sercan Ergun Mustafa Ula?l? Gülper Nacarkahya Yusuf Ziya I?ci Mehri I?ci Recep Bayraktar Ali Tamer Ecir Ali ?akmak Ahmet Arslan | 2014 | Molecular Biology Reports2014，，6： | 1 |
| 11 | Knowledge regarding celiac disease among healthcare professionals,patients and their caregivers in Turkey显示文摘BACKGROUND Celiac disease(CD)is one of the most prevalent chronic disorders.The clinical manifestations of CD are diverse and may present with gastrointestinal findings,extra-intestinal findings or no symptoms.Although there has been a marked increase in the prevalence of CD in the past 30 years,up to 95%of patients with CD remain undiagnosed.As most cases have atypical signs or no symptoms,the diagnosis of CD is either missed or delayed.In addition,one of the most important reasons for the delay in diagnosis may be the poor knowledge of healthcare professionals(HCPs)regarding CD.AIM To evaluate the knowledge of HCPs,patients and their caregivers(parents)regarding CD.METHODS The current study was carried out between June 2021 and February 2022 prospectively,as part of the Focus IN CD project.Patients with CD and their caregivers participated in the study from 6 different cities in Turkey.General practitioners,pediatricians,pediatricians with other subspecialities and pediatric gastroenterologists from different cities participated in the study.RESULTS The questionnaire was completed by 348 HCPs,34 patients with CD,and 102 mothers and 34 fathers of patients with CD.Most of the participants were general practitioners(37.07%).There were 89(25.57%)pediatricians and 72(20.69%)pediatric gastroenterologists in the study.The highest score in all categories was achieved by pediatric gastroenterologists.There were significant differences between the four groups of HCPs in terms of the subsections of overall mean score,epidemiology and clinical presentation,treatment and follow-up.No significant difference was found between the groups(patients with CD,mothers of patients with CD and fathers of patients with CD)in terms of the questionnaire subsections.CONCLUSION The level of knowledge on CD among HCPs,patients and their caregivers was unsatisfactory.We consider that it is necessary to increase awareness and to develop e-learning activities on CD among HCPs,patients and their caregivers.Consequently,they may benefit from e-learning programs similar to the one created as part of the EU-funded project Focus IN CD(http://gffzz2d40e08726724362s9pq50vxw9pfo666b.ffgz.tsg.suse.edu.cn/focusincd-en). | Yasin Sahin Eylem Sevinc Nevzat Aykut Bayrak Fatma Ilknur Varol Ulas Emre Akbulut Ayşegül Bükülmez | 2022 | World Journal of Gastrointestinal Pathophysiology2022，13，6： | 0 |
| 12 | Intensive care outcomes in adult hematopoietic stem cell transplantation patients显示文摘Although outcomes of intensive care for patients undergoing hematopoietic stem cell transplantation(HSCT)have improved in the last two decades, the short-term mortality still remains above 50% among allogeneic HSCT patients. Better selection of HSCT patients for intensive care, and consequently reduction of nonbeneficial care, may reduce financial costs and alleviate patient suffering. We reviewed the studies on intensive care outcomes of patients undergoing HSCT published since 2000. The risk factors for intensive care unit(ICU) admission identified in this report were primarily patient and transplant related: HSCT type(autologous vs allogeneic), conditioning intensity, HLA mismatch, and graft-versus-host disease(GVHD). At the same time, most of the factors associated with ICU outcomes reported were related to the patients' functional status upon development of critical illness and interventions in ICU. Among the many possible interventions, the initiation of mechanical ventilation was the most consistently reported factor affecting ICU survival. As a consequence, our current ability to assess the benefit or futility of intensive care is limited. Until better ICU or hospital mortality prediction models are available, based on the available evidence, we recommend practitioners to base their ICU admission decisions on: Patient pretransplant comorbidities, underlying disease status, GVHD diagnosis/grade, and patients' functional status at the time of critical illness. | Ulas D Bayraktar Joseph L Nates | 2016 | World Journal of Clinical Oncology2016，7，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员